These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23116399)

  • 1. Target sites for the design of anti-trypanosomatid drugs based on the structure of dihydroorotate dehydrogenase.
    Pinheiro MP; Emery Fda S; Nonato MC
    Curr Pharm Des; 2013; 19(14):2615-27. PubMed ID: 23116399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of Trypanosoma cruzi dihydroorotate dehydrogenase from Y strain.
    Pinheiro MP; Iulek J; Cristina Nonato M
    Biochem Biophys Res Commun; 2008 May; 369(3):812-7. PubMed ID: 18302934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of dihydroorotate dehydrogenase from Leishmania major.
    Cordeiro AT; Feliciano PR; Pinheiro MP; Nonato MC
    Biochimie; 2012 Aug; 94(8):1739-48. PubMed ID: 22542640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent developments in the medicinal chemistry and therapeutic potential of dihydroorotate dehydrogenase (DHODH) inhibitors.
    Vyas VK; Ghate M
    Mini Rev Med Chem; 2011 Oct; 11(12):1039-55. PubMed ID: 21861807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dihydroorotate dehydrogenases: Past and present.
    Reis RAG; Calil FA; Feliciano PR; Pinheiro MP; Nonato MC
    Arch Biochem Biophys; 2017 Oct; 632():175-191. PubMed ID: 28666740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant production, crystallization and crystal structure determination of dihydroorotate dehydrogenase from Leishmania (Viannia) braziliensis.
    Reis RA; Lorenzato E; Silva VC; Nonato MC
    Acta Crystallogr F Struct Biol Commun; 2015 May; 71(Pt 5):547-52. PubMed ID: 25945707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydroorotate dehydrogenase inhibitors in anti-infective drug research.
    Boschi D; Pippione AC; Sainas S; Lolli ML
    Eur J Med Chem; 2019 Dec; 183():111681. PubMed ID: 31557612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for the function and inhibition of dihydroorotate dehydrogenase from Schistosoma mansoni.
    de Mori RM; Aleixo MAA; Zapata LCC; Calil FA; Emery FS; Nonato MC
    FEBS J; 2021 Feb; 288(3):930-944. PubMed ID: 32428996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel insights for dihydroorotate dehydrogenase class 1A inhibitors discovery.
    Cheleski J; Rocha JR; Pinheiro MP; Wiggers HJ; da Silva AB; Nonato MC; Montanari CA
    Eur J Med Chem; 2010 Dec; 45(12):5899-909. PubMed ID: 20965617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cysteine peptidase inhibitors in trypanosomatid parasites.
    Lima AP; Reis FC; Costa TF
    Curr Med Chem; 2013; 20(25):3152-73. PubMed ID: 23514421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dihydroorotate dehydrogenase (DHODH) inhibitors on the growth of Theileria equi and Babesia caballi in vitro.
    Kamyingkird K; Cao S; Tuvshintulga B; Salama A; Mousa AA; Efstratiou A; Nishikawa Y; Yokoyama N; Igarashi I; Xuan X
    Exp Parasitol; 2017 May; 176():59-65. PubMed ID: 28286324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human pyrimidine nucleotide biosynthesis as a target for antiviral chemotherapy.
    Okesli A; Khosla C; Bassik MC
    Curr Opin Biotechnol; 2017 Dec; 48():127-134. PubMed ID: 28458037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revisiting the role of dihydroorotate dehydrogenase as a therapeutic target for cancer.
    Madak JT; Bankhead A; Cuthbertson CR; Showalter HD; Neamati N
    Pharmacol Ther; 2019 Mar; 195():111-131. PubMed ID: 30347213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The origin of dihydroorotate dehydrogenase genes of kinetoplastids, with special reference to their biological significance and adaptation to anaerobic, parasitic conditions.
    Annoura T; Nara T; Makiuchi T; Hashimoto T; Aoki T
    J Mol Evol; 2005 Jan; 60(1):113-27. PubMed ID: 15696374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Trypanosoma brucei dihydroorotate dehydrogenase as a possible drug target; structural, kinetic and RNAi studies.
    Arakaki TL; Buckner FS; Gillespie JR; Malmquist NA; Phillips MA; Kalyuzhniy O; Luft JR; Detitta GT; Verlinde CL; Van Voorhis WC; Hol WG; Merritt EA
    Mol Microbiol; 2008 Apr; 68(1):37-50. PubMed ID: 18312275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parasite prolyl oligopeptidases and the challenge of designing chemotherapeuticals for Chagas disease, leishmaniasis and African trypanosomiasis.
    Bastos IM; Motta FN; Grellier P; Santana JM
    Curr Med Chem; 2013; 20(25):3103-15. PubMed ID: 23514419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural products as inhibitors of Leishmania major dihydroorotate dehydrogenase.
    Chibli LA; Schmidt TJ; Nonato MC; Calil FA; Da Costa FB
    Eur J Med Chem; 2018 Sep; 157():852-866. PubMed ID: 30145372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of the putative dihydroorotate dehydrogenase from Streptococcus mutans.
    Liu Y; Gao ZQ; Liu CP; Xu JH; Li LF; Ji CN; Su XD; Dong YH
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2011 Feb; 67(Pt 2):182-7. PubMed ID: 21301083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-throughput screening for potent and selective inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase.
    Baldwin J; Michnoff CH; Malmquist NA; White J; Roth MG; Rathod PK; Phillips MA
    J Biol Chem; 2005 Jun; 280(23):21847-53. PubMed ID: 15795226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel series of human dihydroorotate dehydrogenase inhibitors discovered by in vitro screening: inhibition activity and crystallographic binding mode.
    Zeng T; Zuo Z; Luo Y; Zhao Y; Yu Y; Chen Q
    FEBS Open Bio; 2019 Aug; 9(8):1348-1354. PubMed ID: 31087527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.